List of Excipients in API relugolix, estradiol hemihydrate, and norethindrone acetate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing relugolix, estradiol hemihydrate, and norethindrone acetate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Sumitomo Pharma America Inc | MYFEMBREE | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 | FERRIC OXIDE YELLOW | 2026-01-28 |
| Sumitomo Pharma America Inc | MYFEMBREE | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 | HYDROXYPROPYL CELLULOSE | 2026-01-28 |
| Sumitomo Pharma America Inc | MYFEMBREE | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 | HYPROMELLOSE 2910 | 2026-01-28 |
| Sumitomo Pharma America Inc | MYFEMBREE | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 | LACTOSE MONOHYDRATE | 2026-01-28 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for relugolix, estradiol hemihydrate, and norethindrone acetate
Excipient focus: FERRIC OXIDE YELLOW
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Sumitomo Pharma America Inc | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 |
| >Company | >Ingredient | >NDC |
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sumitomo Pharma America Inc | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 |
| >Company | >Ingredient | >NDC |
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Sumitomo Pharma America Inc | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 |
| >Company | >Ingredient | >NDC |
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Sumitomo Pharma America Inc | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 |
| >Company | >Ingredient | >NDC |
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Sumitomo Pharma America Inc | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 |
| >Company | >Ingredient | >NDC |
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Sumitomo Pharma America Inc | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 |
| >Company | >Ingredient | >NDC |
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Sumitomo Pharma America Inc | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 |
| >Company | >Ingredient | >NDC |
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Sumitomo Pharma America Inc | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 |
| >Company | >Ingredient | >NDC |
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Sumitomo Pharma America Inc | relugolix, estradiol hemihydrate, and norethindrone acetate | 72974-415 |
| >Company | >Ingredient | >NDC |
relugolix, estradiol hemihydrate, and norethindrone acetate drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
